Evidence map›Paper›PMID 32999043›Full record

ArticleMolecular cancer therapeutics2020

Implication of

Branden A Smeester, Garrett M Draper, Nicholas J Slipek, Alex T Larsson, Natalie Stratton, Emily J Pomeroy, Kelsie L Becklin, Kenta Yamamoto, Kyle B Williams, Kanut Laoharawee and 9 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular cancer therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 2 countries.

Branden A Smeester *Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0001-9421-1711
Garrett M Draper *Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-4972-8233
Nicholas J SlipekCenter for Genome Engineering, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0003-2664-6507
Alex T LarssonCenter for Genome Engineering, University of Minnesota, Minneapolis, Minnesota.
Natalie StrattonDepartment of Pediatrics, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0001-7158-1664
Emily J PomeroyDepartment of Pediatrics, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0001-7690-3570
Kelsie L BecklinDepartment of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
Kenta YamamotoDepartment of Pediatrics, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-9424-1993
Kyle B WilliamsDepartment of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
Kanut LaoharaweeDepartment of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
Joseph J PetersonDepartment of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
Juan E AbrahanteUMII, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-9074-4307
Susan K RatheMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Lauren J MillsDepartment of Pediatrics, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-8914-2587
Margaret R CrosbyDepartment of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
Wendy A HudsonAHCSH Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Eric P RahrmannCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, England.ORCID 0000-0003-2369-0342
David A LargaespadaDepartment of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
Branden S MoriarityDepartment of Pediatrics, University of Minnesota, Minneapolis, Minnesota. mori0164@umn.edu.
University of Minnesota · USCancer Research UK Cambridge Center · GB

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
Musculoskeletal Training GrantT32AR050938 · NIAMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI CLOHISY, DENIS R · 2004 to 2020
$3.0M
Sleeping Beauty for uncovering cancer genes in miceR01CA113636 · NCI · UNIVERSITY OF MINNESOTA · PI LARGAESPADA, DAVID ANDREW · 2006 to 2016
$2.5M
Stem Cell Biology Training ProgramT32GM113846 · NIGMS · UNIVERSITY OF MINNESOTA · PI PERLINGEIRO, RITA C. R. · 2015 to 2019
$712k
NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA113636NIAMS NIH HHS T32 AR050938NIGMS NIH HHS T32 GM113846
6 · The paper itself

Abstract

We previously identified

Indexed as

Biomarkers, TumorSignal TransductionAnimalsAntineoplastic AgentsCell Line, TumorCell ProliferationCell Transformation, NeoplasticDisease Models, AnimalEctopic Gene ExpressionGene AmplificationGene Expression Regulation, NeoplasticHumansMiceModels, BiologicalOsteosarcomaPhosphatidylinositol 3-KinasesAntineoplastic AgentsBiomarkers, TumorPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTrans-ActivatorsZNF217 protein, human

Identifiers

PMID32999043
PMCPMC8290861
OpenAlexW3089517233

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.